awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q53114614-75D00126-622C-4E14-9B20-5504738C9607
Q53114614-75D00126-622C-4E14-9B20-5504738C9607
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53114614-75D00126-622C-4E14-9B20-5504738C9607
High dose salvage therapy with dose intensive cyclophosphamide, etoposide and cisplatin may increase transplant rates for relapsed/refractory aggressive non-Hodgkin lymphoma.
P2860
Q53114614-75D00126-622C-4E14-9B20-5504738C9607
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53114614-75D00126-622C-4E14-9B20-5504738C9607
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5095305d4bd721553f59fc4a9618014dabdff4c
P2860
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.